Enanta Pharmaceuticals | Capitale Ordinario

Ordinary Share Capital Cambiamento Data
AbbVie USD 18M 0 2023-09
Amgen USD 32.75B 152M 2023-09
Arrowhead Research USD 200K 0 2023-12
AstraZeneca USD 387M 0 2023-09
Gilead Sciences USD 1000K 0 2023-09
GlaxoSmithKline GBP 1.35B 0 2023-09
Halozyme Therapeutics USD 127K 5K 2023-12
Incyte USD 224K 0 2023-12
Insmed USD 1.48M 50K 2023-12
Ionis Pharmaceuticals USD 144K 1000 2023-12
Ligand Pharmaceuticals USD 18K 0 2023-12
Neurocrine Biosciences USD 100K 0 2023-09
Pfizer USD 478M 0 2023-09
Roche Holding CHF 107M 0 2023-06
Sarepta Therapeutics USD 9K 0 2023-09
Vertex Pharmaceuticals USD 2.6M 0 2023-09



Enanta Pharmaceuticals Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.